Much of the existing dermatologic research has focused on the classical TGF-β pathway, and only recently has there been an investigation into how PFD inhibits fibroblast proliferation through dampening of the Wnt/GSK-3β/β-catenin cascade [50]. Here, GSK3B is linked to polyostotic fibrous dysplasia.